Treatment of Aggressive Localized Lymphoma

NCT00841945 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

334

Enrollment

OTHER

Sponsor class

Stopped other drugs other studies

Conditions

B Cell Lymphoma

Interventions

DRUG: rituximab
DRUG: doxorubicin
DRUG: vincristine
DRUG: prednisone
PROCEDURE: radiotherapy

Sponsor

French Innovative Leukemia Organisation